LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 1244

Search options

  1. Article: In Patients with Early Peripheral Psoriatic Arthritis Baseline C-Reactive Protein, Pain and Ultrasound-Detected Synovitis Predict Subsequent Treatment with ts/bDMARDs. A Retrospective Analysis.

    Sakellariou, Garifallia / Quaglini, Silvana / Bugatti, Serena / Bobbio-Pallavicini, Francesca / Gabba, Vittorio / Montecucco, Carlomaurizio

    Journal of clinical medicine

    2021  Volume 10, Issue 13

    Abstract: ... 12.25) months. In univariate analyses, C-reactive protein (RR, 95% CI 1.204 (1.065,1.362)), Visual ... predictors. C-reactive protein, VAS pain and PD confirmed their predictive value also in multivariate models ...

    Abstract With the availability of effective treatment with targeted synthetic and biologic disease-modifying anti-rheumatic drugs (ts/bDMARDs) for psoriatic arthritis (PsA), it is crucial to identify predictors of access to this treatment since disease onset. We retrospectively enrolled patients with peripheral PsA, assessed in an early arthritis clinic from 2005 to 2020. The main baseline demographic, clinical and ultrasonographic (assessment of bilateral wrist and metacarpophalangeal joints) features were evaluated through descriptive statistics and tested as predictors by univariate and multivariate Cox models. The outcome of interest was the indication for ts/bDMARDs within 2 years from diagnosis. We included 238 patients with PsA, with a mean (sd) age of 51.04 (13.98) years; 90 (37.8%) were male, and the median (IQR) symptom duration was 6.12 (3.29-12.25) months. In univariate analyses, C-reactive protein (RR, 95% CI 1.204 (1.065,1.362)), Visual Analogue Scale (VAS) pain (1.027 (1.005,1.048)), the number of tender joints on 28 joints (1.087 (1.025, 1.153)), and a synovial power Doppler (PD) score > 1 (3.63 (1.307, 10.08)) emerged as significant predictors. C-reactive protein, VAS pain and PD confirmed their predictive value also in multivariate models. These results provide preliminary evidence on the features that might characterize patients with early peripheral PsA requiring more intensive monitoring and treatment escalation.
    Language English
    Publishing date 2021-06-27
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm10132834
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Prognostic and therapeutic considerations of antibodies against c-ter apolipoprotein A-1 in the general population.

    Vuilleumier, Nicolas / Antiochos, Panagiotis / Marques-Vidal, Pedro / Pagano, Sabrina / Virzi, Julien / Satta, Nathalie / Hartley, Oliver / Gaertner, Hubert / Brandt, Karim J / Burger, Fabienne / Montecucco, Fabrizio / Waeber, Gerard / Mach, François / Vollenweider, Peter

    Clinical & translational immunology

    2020  Volume 9, Issue 12, Page(s) e1220

    Abstract: Objectives: Autoantibodies against apolipoprotein A1 (anti-apoA1 IgGs) and its C-terminal region ...

    Abstract Objectives: Autoantibodies against apolipoprotein A1 (anti-apoA1 IgGs) and its C-terminal region (cter apoA1) have emerged as an independent biomarker for cardiovascular disease. Cter apoA1 mimetic peptides were shown to reverse the deleterious anti-apoA1 IgG effects
    Methods: Anti-cter apoA1 IgGs were measured in serum samples of 6386 participants of the CoLaus study of which 5220 were followed for a median duration of 5.6 years. The primary outcome was overall mortality. The peptide inhibitory concentration 50% (IC
    Results: Anti-cter apoA1 IgGs were associated with higher interleukin 6 levels and independently predicted overall mortality; an increase of one standard deviation of anti-cter apoA1 IgG level was associated with an 18% increase in mortality risk (hazard ratio: 1.18, 95% confidence interval: 1.04-1.33;
    Conclusion: Anti-cter apoA1 IgG independently predicts overall mortality in the general population. Despite being effective
    Language English
    Publishing date 2020-12-14
    Publishing country Australia
    Document type Journal Article
    ZDB-ID 2694482-0
    ISSN 2050-0068
    ISSN 2050-0068
    DOI 10.1002/cti2.1220
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: C-Reactive Protein Levels at the Midpregnancy Can Predict Gestational Complications.

    Vecchié, Alessandra / Bonaventura, Aldo / Carbone, Federico / Maggi, Davide / Ferraiolo, Antonella / Carloni, Beatrice / Andraghetti, Gabriella / Affinito Bonabello, Laura / Liberale, Luca / Dallegri, Franco / Montecucco, Fabrizio / Cordera, Renzo

    BioMed research international

    2018  Volume 2018, Page(s) 1070151

    Abstract: ... we assessed the accuracy of maternal C-reactive protein (CRP) concentrations at the middle phase of pregnancy ...

    Abstract Although essential for a successful pregnancy, a growing body of evidence suggests that maternal inflammation, when dysregulated, may represent a risk factor for both maternal and neonatal outcomes. Here, we assessed the accuracy of maternal C-reactive protein (CRP) concentrations at the middle phase of pregnancy in the identification of maternal adverse outcomes (MAO) until delivery. A correlation between CRP and a complicated pregnancy including both maternal and neonatal adverse outcomes has been investigated, too. In this retrospective study, conducted at the Diabetology Unit of IRCCS Ospedale Policlinico San Martino, Genoa (Italy), 380 outpatient pregnant women have been enrolled at the prenatal visit before performing a 75 g oral glucose tolerance test at 24th-26th gestational week for gestational diabetes mellitus (GDM) screening. Demographic, medical, and reproductive history has been obtained by verbal interview. Data about pregnancy and delivery have been retrieved from medical records. The median value of maternal baseline serum CRP was 3.25
    MeSH term(s) Adult ; C-Reactive Protein/metabolism ; Cohort Studies ; Female ; Humans ; Infant, Newborn ; Logistic Models ; Pregnancy ; Pregnancy Complications/blood ; Pregnancy Complications/diagnosis ; Pregnancy Outcome ; ROC Curve
    Chemical Substances C-Reactive Protein (9007-41-4)
    Language English
    Publishing date 2018-11-07
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2698540-8
    ISSN 2314-6141 ; 2314-6133
    ISSN (online) 2314-6141
    ISSN 2314-6133
    DOI 10.1155/2018/1070151
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Impact of fibrates on circulating cystatin C levels: a systematic review and meta-analysis of clinical trials.

    Sahebkar, Amirhossein / Simental-Mendía, Luis E / Pirro, Matteo / Montecucco, Fabrizio / Carbone, Federico / Banach, Maciej / Barreto, George E / Butler, Alexandra E

    Annals of medicine

    2018  Volume 50, Issue 6, Page(s) 485–493

    Abstract: Aims: To assess the effect of fibrates on circulating cystatin C levels.: Material and methods ... Clinical studies evaluating the effect of a fibrate on circulating cystatin C levels were searched ... confounders on cystatin C levels.: Results: This meta-analysis of data from nine published studies (16 ...

    Abstract Aims: To assess the effect of fibrates on circulating cystatin C levels.
    Material and methods: Clinical studies evaluating the effect of a fibrate on circulating cystatin C levels were searched in PubMed-Medline, SCOPUS, Web of Science, and Google Scholar databases. A random-effect model and generic inverse variance method were used for quantitative data synthesis, sensitivity analysis conducted using the leave-one-out method, and weighted random-effects meta-regression performed to evaluate potential confounders on cystatin C levels.
    Results: This meta-analysis of data from nine published studies (16 treatment arms) involved a total of 2195 subjects. In a single-arm analysis of clinical trials (without control group; eight studies comprising 14 treatment arms), fibrate therapy increased circulating cystatin C concentrations (WMD: 0.07 mg/dL, 95% CI: 0.04, 0.10, p < .001; I
    Conclusions: The results suggest that fenofibrate treatment adversely affects cystatin C levels and might partially explain the limited efficacy of fenofibrate in reducing cardiovascular events. Key message Fenofibrate treatment adversely affects cystatin C levels and might partially explain the limited efficacy of fenofibrate in reducing cardiovascular events.
    MeSH term(s) Cardiovascular Diseases/blood ; Cardiovascular Diseases/pathology ; Cardiovascular Diseases/prevention & control ; Cholesterol, LDL/antagonists & inhibitors ; Cholesterol, LDL/blood ; Clinical Trials as Topic ; Cystatin C/blood ; Cystatin C/metabolism ; Fibric Acids/pharmacology ; Fibric Acids/therapeutic use ; Humans ; Hypertriglyceridemia/blood ; Hypertriglyceridemia/drug therapy ; Hypolipidemic Agents/pharmacology ; Hypolipidemic Agents/therapeutic use ; PPAR alpha/agonists ; Treatment Outcome
    Chemical Substances Cholesterol, LDL ; Cystatin C ; Fibric Acids ; Hypolipidemic Agents ; PPAR alpha ; PPARA protein, human
    Language English
    Publishing date 2018-09-07
    Publishing country England
    Document type Journal Article ; Meta-Analysis ; Systematic Review
    ZDB-ID 1004226-x
    ISSN 1365-2060 ; 1651-2219 ; 0785-3890 ; 1743-1387
    ISSN (online) 1365-2060 ; 1651-2219
    ISSN 0785-3890 ; 1743-1387
    DOI 10.1080/07853890.2018.1495338
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Low serum C-reactive protein levels predict 90-day mortality in hypoglycaemic patients.

    Bonaventura, A / Gallo, F / Carbone, F / Sacchi, G / Liberale, L / Dallegri, F / Maggi, D / Montecucco, F / Cordera, R

    Diabetes & metabolism

    2017  Volume 43, Issue 6, Page(s) 554–556

    MeSH term(s) Aged ; Aged, 80 and over ; C-Reactive Protein/analysis ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/drug therapy ; Diabetes Mellitus, Type 2/epidemiology ; Female ; Humans ; Hypoglycemia/blood ; Hypoglycemia/complications ; Hypoglycemia/epidemiology ; Hypoglycemia/mortality ; Hypoglycemic Agents/therapeutic use ; Insulin/therapeutic use ; Male ; Predictive Value of Tests
    Chemical Substances Hypoglycemic Agents ; Insulin ; C-Reactive Protein (9007-41-4)
    Language English
    Publishing date 2017-07-04
    Publishing country France
    Document type Letter ; Observational Study
    ZDB-ID 1315751-6
    ISSN 1878-1780 ; 1262-3636 ; 0338-1684
    ISSN (online) 1878-1780
    ISSN 1262-3636 ; 0338-1684
    DOI 10.1016/j.diabet.2017.05.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Time course and temperature dependence of the membrane translocation of tetanus and botulinum neurotoxins C and D in neurons.

    Pirazzini, Marco / Rossetto, Ornella / Bertasio, Cristina / Bordin, Fulvio / Shone, Clifford C / Binz, Thomas / Montecucco, Cesare

    Biochemical and biophysical research communications

    2013  Volume 430, Issue 1, Page(s) 38–42

    Abstract: ... course of the entry of the L chain of tetanus neurotoxin and of botulinum neurotoxins type C and D across ... BoNT/C does not enter neurons at 20 °C. Translocation also depends on the dimension of the pH gradient ... for the three neurotoxins, but it remains in the range of minutes at 37 °C, whilst it takes much longer at 20 °C ...

    Abstract Tetanus and botulinum neurotoxins act inside nerve terminals and, therefore, they have to translocate across a membrane to reach their targets. This translocation is driven by a pH gradient, acidic on the cis side and neutral on the cytosol. Recently, a protocol to induce translocation from the plasma membrane was established. Here, we have used this approach to study the temperature dependence and time course of the entry of the L chain of tetanus neurotoxin and of botulinum neurotoxins type C and D across the plasma membrane of cerebellar granular neurons. The time course of translocation of the L chain varies for the three neurotoxins, but it remains in the range of minutes at 37 °C, whilst it takes much longer at 20 °C. BoNT/C does not enter neurons at 20 °C. Translocation also depends on the dimension of the pH gradient. These data are discussed with respect to the contribution of the membrane translocation step to the total time to paralysis and to the low toxicity of these neurotoxins in cold-blood vertebrates.
    MeSH term(s) Animals ; Botulinum Toxins/metabolism ; Botulinum Toxins/toxicity ; Cell Membrane/enzymology ; Cells, Cultured ; Hydrogen-Ion Concentration ; Metalloendopeptidases/metabolism ; Metalloendopeptidases/toxicity ; Neurons/drug effects ; Neurons/metabolism ; Protein Biosynthesis ; Rats ; Synaptosomal-Associated Protein 25/metabolism ; Temperature ; Tetanus Toxin/metabolism ; Tetanus Toxin/toxicity ; Time Factors
    Chemical Substances Synaptosomal-Associated Protein 25 ; Tetanus Toxin ; tetanospasmin (11032-48-7) ; botulinum toxin type D (331HTW151K) ; Metalloendopeptidases (EC 3.4.24.-) ; Botulinum Toxins (EC 3.4.24.69) ; botulinum toxin type C (FPM7829VMX)
    Language English
    Publishing date 2013-01-04
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 205723-2
    ISSN 1090-2104 ; 0006-291X ; 0006-291X
    ISSN (online) 1090-2104 ; 0006-291X
    ISSN 0006-291X
    DOI 10.1016/j.bbrc.2012.11.048
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: C-Reactive Protein Levels at the Midpregnancy Can Predict Gestational Complications

    Alessandra Vecchié / Aldo Bonaventura / Federico Carbone / Davide Maggi / Antonella Ferraiolo / Beatrice Carloni / Gabriella Andraghetti / Laura Affinito Bonabello / Luca Liberale / Franco Dallegri / Fabrizio Montecucco / Renzo Cordera

    BioMed Research International, Vol

    2018  Volume 2018

    Abstract: ... we assessed the accuracy of maternal C-reactive protein (CRP) concentrations at the middle phase of pregnancy ...

    Abstract Although essential for a successful pregnancy, a growing body of evidence suggests that maternal inflammation, when dysregulated, may represent a risk factor for both maternal and neonatal outcomes. Here, we assessed the accuracy of maternal C-reactive protein (CRP) concentrations at the middle phase of pregnancy in the identification of maternal adverse outcomes (MAO) until delivery. A correlation between CRP and a complicated pregnancy including both maternal and neonatal adverse outcomes has been investigated, too. In this retrospective study, conducted at the Diabetology Unit of IRCCS Ospedale Policlinico San Martino, Genoa (Italy), 380 outpatient pregnant women have been enrolled at the prenatal visit before performing a 75 g oral glucose tolerance test at 24th-26th gestational week for gestational diabetes mellitus (GDM) screening. Demographic, medical, and reproductive history has been obtained by verbal interview. Data about pregnancy and delivery have been retrieved from medical records. The median value of maternal baseline serum CRP was 3.25 μg/mL. Women experiencing MAO were older, more frequently suffering from hypertension, and showed higher CRP concentrations, with a cutoff value >1.86 μg/mL found by a ROC curve analysis to be accurately predictive for MAO. By a logistic regression analysis, serum CRP levels >1.86 μg/mL have been found to predict MAO also considering maternal age, hypertension, and GDM. Maternal CRP levels have been positively associated with overall pregnancy adverse outcomes (maternal and neonatal), too. In conclusion, in pregnant women serum levels of CRP can early recognize subjects at higher risk for maternal and neonatal complications needing a more stringent follow-up.
    Keywords Medicine ; R
    Subject code 610
    Language English
    Publishing date 2018-01-01T00:00:00Z
    Publisher Hindawi Limited
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: In Patients with Early Peripheral Psoriatic Arthritis Baseline C-Reactive Protein, Pain and Ultrasound-Detected Synovitis Predict Subsequent Treatment with ts/bDMARDs. A Retrospective Analysis

    Garifallia Sakellariou / Silvana Quaglini / Serena Bugatti / Francesca Bobbio-Pallavicini / Vittorio Gabba / Carlomaurizio Montecucco

    Journal of Clinical Medicine, Vol 10, Iss 2834, p

    2021  Volume 2834

    Abstract: ... 12.25) months. In univariate analyses, C-reactive protein (RR, 95% CI 1.204 (1.065,1.362)), Visual ... predictors. C-reactive protein, VAS pain and PD confirmed their predictive value also in multivariate models ...

    Abstract With the availability of effective treatment with targeted synthetic and biologic disease-modifying anti-rheumatic drugs (ts/bDMARDs) for psoriatic arthritis (PsA), it is crucial to identify predictors of access to this treatment since disease onset. We retrospectively enrolled patients with peripheral PsA, assessed in an early arthritis clinic from 2005 to 2020. The main baseline demographic, clinical and ultrasonographic (assessment of bilateral wrist and metacarpophalangeal joints) features were evaluated through descriptive statistics and tested as predictors by univariate and multivariate Cox models. The outcome of interest was the indication for ts/bDMARDs within 2 years from diagnosis. We included 238 patients with PsA, with a mean (sd) age of 51.04 (13.98) years; 90 (37.8%) were male, and the median (IQR) symptom duration was 6.12 (3.29–12.25) months. In univariate analyses, C-reactive protein (RR, 95% CI 1.204 (1.065,1.362)), Visual Analogue Scale (VAS) pain (1.027 (1.005,1.048)), the number of tender joints on 28 joints (1.087 (1.025, 1.153)), and a synovial power Doppler (PD) score > 1 (3.63 (1.307, 10.08)) emerged as significant predictors. C-reactive protein, VAS pain and PD confirmed their predictive value also in multivariate models. These results provide preliminary evidence on the features that might characterize patients with early peripheral PsA requiring more intensive monitoring and treatment escalation.
    Keywords psoriatic arthritis ; early arthritis ; disease-modifying anti-rheumatic drugs ; predictors ; Medicine ; R
    Subject code 616 ; 610
    Language English
    Publishing date 2021-06-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Book: Italian Society for Rheumatology (SIR) guidelines on the use of biologics in rheumatic diseases

    Montecucco, Carlomaurizio

    (Clinical and experimental rheumatology : Suppl. ; 66)

    2011  

    Institution Società Italiana di Reumatologia
    Author's details C. Montecucco
    Series title Clinical and experimental rheumatology : Suppl. ; 66
    Clinical and experimental rheumatology
    Clinical and experimental rheumatology ; Suppl.
    Collection Clinical and experimental rheumatology
    Clinical and experimental rheumatology ; Suppl.
    Language English
    Size S-62 S.
    Publishing place Pisa
    Publishing country Italy
    Document type Book
    HBZ-ID HT017008588
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  10. Article ; Online: The C-terminal region of a Lys49 myotoxin mediates Ca2+ influx in C2C12 myotubes.

    Cintra-Francischinelli, Mariana / Pizzo, Paola / Angulo, Yamileth / Gutiérrez, José M / Montecucco, Cesare / Lomonte, Bruno

    Toxicon : official journal of the International Society on Toxinology

    2009  Volume 55, Issue 2-3, Page(s) 590–596

    Abstract: ... in skeletal muscle tissue. Their mechanisms of action are still poorly understood, but there is evidence that the C ... terminal region is involved in membrane damage leading to myotoxicity. To investigate the effect of the C ... by the C-terminal peptide, but not by its scrambled version control, reproduces the second, prominent wave ...

    Abstract Myotoxins are abundant components of snake venoms, being a significant public health problem worldwide. Among them, Lys49 phospholipase A(2) homologue myotoxins cause extensive necrosis in skeletal muscle tissue. Their mechanisms of action are still poorly understood, but there is evidence that the C-terminal region is involved in membrane damage leading to myotoxicity. To investigate the effect of the C-terminal peptide 115-129 of Agkistrodon contortrix laticinctus myotoxin on the plasma membrane of myoblasts and myotubes, the entry of Ca(2+) was monitored by fluorescence imaging, and the ensuing cytotoxicity was determined. The myotoxin synthetic peptide was found to act selectively on myotubes, which were rapidly overloaded with Ca(2+) with ensuing necrosis. The profile of intracellular Ca(2+) increase induced by the C-terminal peptide, but not by its scrambled version control, reproduces the second, prominent wave of the biphasic response documented in previous studies using whole Lys49 myotoxins. These observations provide relevant insights into the mechanism of action of this family of toxins, with implications for the understanding of their structure-function relationships.
    MeSH term(s) Agkistrodon ; Animals ; Calcium/metabolism ; Cell Line ; Cell Survival/drug effects ; Mice ; Muscle Fibers, Skeletal/drug effects ; Muscle Fibers, Skeletal/metabolism ; Muscle, Skeletal/drug effects ; Muscle, Skeletal/metabolism ; Myoblasts/drug effects ; Myoblasts/metabolism ; Peptides/chemistry ; Peptides/toxicity ; Phospholipases A2/toxicity ; Structure-Activity Relationship ; Viper Venoms/enzymology ; Viper Venoms/toxicity
    Chemical Substances Peptides ; Viper Venoms ; Phospholipases A2 (EC 3.1.1.4) ; Calcium (SY7Q814VUP)
    Language English
    Publishing date 2009-10-14
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 204479-1
    ISSN 1879-3150 ; 0041-0101
    ISSN (online) 1879-3150
    ISSN 0041-0101
    DOI 10.1016/j.toxicon.2009.10.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top